Which cannabis products can be prescribed?
Doctors can prescribe the cannabis products that are comprised by the pilot programme and which have been made available by the companies for prescription by doctors and subsequent preparation and dispensing by a pharmacy.
The doctor can prescribe a so-called cannabis product. On the basis of a doctor’s prescription, the pharmacy will then prepare and dispense the cannabis product.
The pharmacy uses a cannabis intermediate product to prepare the cannabis product.
The cannabis intermediate product is manufactured by an intermediate product manufacturer based on an imported cannabis primary product. It is the intermediate product manufacturer who has applied for the concerned cannabis intermediate product to be admitted to the pilot programme.
The preparation carried out by the pharmacy and the intermediate product manufacturer primarily consists of repackaging and labelling of the cannabis product.
Details about the cannabis intermediate products admitted to the pilot programme can be found in the following places:
- in the list of cannabis intermediate products on the website of the Danish Medicines Agency
- in the product sheets on the website of the Danish Medicines Agency
- in the medical practice systems
- on Medicinpriser.dk (medicine prices)
There is no information about the pilot programme’s cannabis products on Produktresume.dk.
Below, we go through the product-specific information that will be available at each different place.
List of admitted cannabis intermediate products
The "List of admitted cannabis intermediate products” allows doctors to gain an overview of the cannabis intermediate products comprised by the programme.
This list describes the strength, product form and pack size of each product.
The product sheet has been completed by the company (intermediate product manufacturer). The information on the product sheet reflects the information on the packaging of the cannabis intermediate product. Accordingly, the product sheet contains the following information:
- Name of the cannabis product
- Product form
- Pack size
- Method of administration, including dosing recommendations
- Method of preparation. Instructions on how to prepare the product are relevant if the product must be prepared before use – consumed as tea for example.
- Storage conditions
- Product number
The product sheets of admitted cannabis intermediate products are available at the website of the Danish Medicines Agency.
Medicinpriser.dk (medicine prices)
The fact that a cannabis product is admitted to the pilot programme does not necessarily mean that it is currently available for prescription by doctors.
Conditions relating to the company, such as supply difficulties, could make a cannabis product unavailable for a certain period.
Doctors can therefore use www.medicinpriser.dk to look up the cannabis products currently available for prescription in their medical practice systems.
On the front page of medicinpriser.dk is a link to an overview of all the cannabis products expected to be prepared and dispensed by a pharmacy. Use this link to go directly to the overview.
From the overview, you can click on the individual cannabis products and get an overview of the specific product’s:
- pack sizes
- intermediate product manufacturer
If you click on a specific pack size, information about any substitutable cannabis products will appear.
Medical practice systems
The various types of medical practice systems will provide information about the cannabis products. The information available may vary between the systems used by the doctors. In the medical practice system, you will be able to see the specific cannabis product’s:
- pack size
- route of administration
- the indications covered by the Danish Medicines Agency’s guidelines for doctors on the medicinal cannabis pilot programme.
If a doctor wants to prescribe a cannabis intermediate product for other indications than those described in the guidelines, some medical practice systems allow for the selection of indications from an extended list. However, not all medical practice systems make the full indication list available.
It is also possible to write the indication in a free-text field, but doctors should only use the free-text field if there is no matching indication in the available indication list.
Dosage recommendations will not be available for doctors through the medical practice system. This is because the intermediate product manufacturer is not required to provide dosage information.
It is thus for the individual doctor to determine the dose considered right for the patient based on the expression of strength, product form, route of administration and the doctor’s knowledge of the active substances and the patient’s specific disease, age, co-administered drugs, etc.